Hemolytic uremic syndrome

Hemolytic-uremic syndrome (HUS) is characterized by a triad of symptoms, which are:
 * 1) Coombs negative hemolytic anemia
 * 2) thrombocytopenia
 * 3)  acute renal failure

HUS is the most common cause of Acute Renal Failure in childhood, with the highest incidence in infancy and toddler age. It can arise from post-infectious causes, where it is either caused by a gastrointestinal infection with enterohemorrhagic E. coli (EHEC) and we classify it as D + HUS (diarrhoea associated HUS), or pneumococcal infection.

Under the designation D− HUS ("diarrhea non-associated HUS") is a heterogeneous group of diseases that are not associated with diarrhea. It usually has a  severe course . It often leads to kidney failure, which is addressed by a  transplant . After transplantation, there is still a risk of  recurrence .

Classification
The term hemolytic uremic syndromes includes a set of diseases, which can be divided according to etiology into post-infectious, which includes both D + HUS, pneumococcal or other HUS infection, and D-HUS ( diarrhea non-associated HUS).

D-HUS can be caused by regulatory disorders in  alternative complement pathways, ADAMTS 13 protease deficiency, congenital metabolic disorders of  vitamin B 12or by a drug reaction to quinine.

However, there is also a HUS for which we do not know the exact etiology. Risk factors then include HIV infection, malignancies, chemotherapy, radiotherapy, transplantation, pregnancy, HELLP syndrome, SLE and more. .

Typical form of D + HUS
Diarrhea associated HUS is a disease characterized by a specific clinical and laboratory picture, caused by the E. coli toxin.

Incidence and epidemiology
It mainly affects infants and toddlers. It is characterized by an endemic occurence with a high incidence, for example in Argentina, and low in Europe. The number of new patients per year corresponds to 2,1 cases per 100&thinsp;000 inhabitants.

Etiology
EHEC colonizes the digestive tract of animals, most often beef cattle.

Verotoxigenic enterohemorrhagic E. coli produces a shiga-like toxin that occurs in multiple forms (so-called serotypes). Serotypes O157: H7, O26, O111, O103 and O145 have the ability to cause disease.

EHEC infection occurs both interhumanly and by transmission from an infected animal or by ingesting its contaminated products (unboiled cow's or goat's milk, insufficiently heat-treated beef ("hamburger-disease")), home-made juices from EHEC-contaminated vegetables, swimming in a pool with contaminated water, etc.).

A small infectious dose is presumed with a probability of developing HUS in 15% of cases. The incubation period is 3-8 days.

Pathogenesis
Upon entry of EHEC into the digestive system, shiga-like toxin (Stx) is released, which adheres to the intestinal mucosa. It enters the bloodstream transcellularly. It binds to endothelial receptors in the blood. Upon binding, a number of inflammatory changes, induction of apoptosis, or blockade of the synthesis of a number of proteins may occur within the cell.

Stx also binds to glomerular capillary receptors, which it damages and at the same time induces local intravascular coagulation.

Diagnostics
Early symptoms include: bloody diarrhea (haemorrhagic enterocolitis), vomiting and fever. Approximately after a week pallor (anemia), petechiae (thrombocytopenia), oliguria, dehydration and swelling (kidney failure), arterial hypertension, haematuria and, if CNS is also affected, neurological symptoms (somnolence, impaired consciousness, convulsions, etc.) can present.

Significant hemolytic anemia with erythrocyte deformity (schistocytes) and thrombocytopenia, which is often very severe, appear in the blood. The result Coombs test is negative. Increased levels of urea, creatinine, lactate dehydrogenase and bilirubin, decreased levels of haptoglobin and normal levels of C3 complement are expected.

We observe proteinuria and hematuria in the urine.

One of the possible examinations is a kidney ultrasound. The pathological finding is an enlarged kidney and an echotexture in the cortex. Another method may be, for example, '"serotyping'" of E. coli or Stx detection in stool or blood.

Therapy
Therapy focuses on symptoms. Transfusions, furosemide, antihypertensives and others are administered. Renal function substitution by peritoneal dialysis or hemofiltration is also possible.

Antibiotics are not recommended due to the breakdown of bacteria, which would lead to further release of Stx.

Prognosis
The decisive factor is the duration of the oligo / anuria. Spontaneous remission should occur in 1-3 weeks. If it does not occur, there is a risk of progression of glomerular filtration disorders and chronic renal failure.

D + HUS is lethal in approximately 5% of cases. Risk factors include late diagnosis, severe hyperhydration, sepsis, and extrarenal symptoms (CNS).

In young children, it is the most common cause of acute kidney failure' requiring elimination treatment.

HUS associated with pneumococcal infection
This type of HUS arises as a complication of primary pneumococcal infection, most often in children under two years of age. It is associated with a difficult course with a mortality of around 30%. Pneumococcus produces the enzyme neuraminidase, which cleaves N-acetylneuramic acid from glycoproteins on the cell membrane of erythrocytes, platelets and glomeruli. This in turn leads to the detection of Thomsen-Friedenreich antigen (T antigen), which can then react with anti T IgM antibodies present in the plasma.

A characteristic presentation is a positive direct Coombs test.

Therapeutically, it is appropriate to use antibiotics or plasmapheresis. Conversely, the use of frozen plasma due to cold hemolysis is contraindicated (IgM has an ideal erythrocyte binding temperature of about 4 degrees).

HUS induced by a complement regulation disorder
In this disorder, pathological activation of the complement system occurs. The mechanism is based on the formation of a membranolytic complex'"with cytotoxic activity. It arises either from a genetic mutation, or by autoantibodies, which lead to the activation of alternative complement pathways. It can often end in  spontaneous remission''', and is treated therapeutically by symptomatic adjustment of the internal environment or dialysis. Another option is plasmapheresis or fresh frozen plasma. Genetically based HUS usually faces a poor prognosis. It often leads to the development of chronic renal failure with a transition to end-stage chronic renal failure. In extreme cases, it is necessary to replace kidney function. In some mutations a very high incidence of recurrence after kidney transplantation is described.

HUS arising from ADAMTS 13 protease deficiency

 *  HUS / TTP (thrombotic thrombocytopenic purpura) ;
 * congenital and acquired form;
 * ADAMTS 13 is a metalloproteinase that cleaves multimers of von Willebrand factor, which binds platelets;
 * with ADAMTS 13 deficiency, thrombi form in many organs (brain, heart, kidneys);
 * clinical picture similar to HUS, fever, more pronounced neurological and hematological symptoms
 * acute renal failure requiring dialysis is rather rare; frequent relapses, transition to chronicity;
 * treatment: frozen plasma, alternativelly plasmapheresis, sometimes immunosuppression, if need be splenectomy.

HUS from other causes

 * based on a congenital defect of vitamin B12 metabolism - manifestation in neonatal or early infant age;
 * after quinine administration,
 * for malignancies very likely in connection with therapy,
 * in patients after organ transplants and bone marrow transplants treated with calcineurin inhibitors;
 * secondary forms after administration of antiaggregants (ticlodipine, clopidogrel);
 * during pregnancy, most often during the 3rd trimester,
 * in HIV patients, in patients with Systemic lupus erythematosus,  antiphospholipid syndrome and in individuals with  chronic glomerulonephritis.

Related articles

 * Acute renal failure
 * Proteinuria in Children
 * Nephrotic Syndrome in Children